Bioscrypt VisionAccess 3D Face Readers meet unique needs of
TORONTO, Aug. 28 /CNW/ - Bioscrypt Inc. (TSX: BYT), a leading provider of
enterprise access control technology, today announced a leading multinational
integrated biopharmaceutical company and one of the fastest growing
pharmaceutical companies on NASDAQ, has chosen Bioscrypt's VisionAccess 3D
facial recognition technology to secure access to its facilities and white
rooms, where it produces pharmaceuticals.
Bioscrypt's 3D facial recognition biometric technology both enhances and
simplifies the Company's access control processes, allowing it to increase
security as well as ease of use for employees. VisionAccess allows employees
to enter facilities using their face as the sole identification factor. This
eliminates the need for badges, which are not allowed in production or white
rooms where employees cannot bring any foreign objects. Bioscrypt's solution
also enabled the Company to better meet regulatory requirements for securing
"With the strong regulations in our business, we have looked at various
solutions to secure our new administration and production site ranging from
Smart Cards, PIN codes and fingerprint biometrics but 3D face recognition from
Bioscrypt was clearly the best solution in the market to secure a
pharmaceutical production site," said the Project Director at the Company. "3D
face provides the high level of security required to secure access to white
rooms where drugs are produced. The solution is extremely quick, elegant and
above all it does not require a badge as no products are allowed inside white
rooms. Our employees have their face as the sole identifier to enter the
building and access the white rooms!"
The company deployed 10 Bioscrypt VisionAccess 3D Face Readers at control
points inside its building as well as additional face readers at the main
entrances at its new administration and production site in Switzerland. As
employees walk up to a door, they pause for less than a second in front of a
reader which confirms their identity against a database, allowing their 3D
facial patterns to be their single identifier.
"We are pleased to provide the Company with a means for securing their
labs in a way that meets the unique requirements of the pharmaceuticals
industry," said Robert M. Douglas, President and CEO of Bioscrypt. "Our
distinctive 3D physical access control reader, VisionAccess, was able to help
the biopharmaceutical company eliminate the need for badge management."
About Bioscrypt Inc.
Bioscrypt is an enterprise access control solution provider, enabling the
unification of physical and logical access with its Door to Desktop(R)
products. Bioscrypt's hardware and software solutions deliver strong
authentication processes to facilities, equipment, IT networks and computer
applications and allow organizations to administer unified identities across
Building on its proven expertise in biometric technology and its unique
multi-factor authentication platform, Bioscrypt integrates all major secure
authentication standards, transforming how organizations are bridging the gap
between physical and logical access to create secure working environments.
More information is available at www.bioscrypt.com.
Forward-looking (safe harbour) statement
Statements made in this news release that relate to future plans, events
or performances are forward-looking statements. Any statement containing words
such as "believes", "plans", "expects" or "intends" and other statements which
are not historical facts contained in this release are forward-looking, and
these statements involve risks and uncertainties and are based on current
expectations. Consequently, actual results could differ materially from the
expectations expressed in these forward-looking statements.
Bioscrypt and Door to Desktop(R) are registered trademarks and
Veri-Series and VeriSoft are trademarks of Bioscrypt Inc. All other
product and company names mentioned are the property of their respective
owners and are mentioned for identification purposes only.
For further information:
For further information: Laura Slater, High Road Communications, (613)
688-1192, firstname.lastname@example.org; Matthew Bogart, Bioscrypt Inc., (905)